Developmental expression of N-acetyltransferases in C57BI/6 mice

Drug Metabolism and Disposition

Volumn 27, Issue 2, 1999, Pages 261-264

  Mitchell, M Kimberly ^a,c   Futscher, Bernard W ^b   McQueen, Charlene A ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; RNA;

ANIMAL TISSUE; ARTICLE; EMBRYO; EMBRYO DEVELOPMENT; EMBRYONAL TISSUE; LIVER; NEWBORN; NONHUMAN; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACETYLTRANSFERASES; ANIMALS; ANIMALS, NEWBORN; ARYLAMINE N-ACETYLTRANSFERASE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EMBRYO; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; ISOENZYMES; LIVER; MICE; MICE, INBRED C57BL; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ANIMALIA;

EID: 0032963585     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Badawi AF, Hirvonen A, Bell DA, Land NP and Kadlubar FF (1995) Role of aromatic amine acetyltransferases NAT1 and NAT2 in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res 55:5230-5237.
2. Blum M, Grant DM, McBride OW, Heim M and Meyer UA (1990) Human arylamine N-acetyltransferase genes: Isolation, chromosomal localization and functional expression. DNA Cell Biol 9:193-203.
3. Blum M, Demierre A, Grant DM, Heim M and Meyer UA (1991) Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proc Natl Acad Sci USA 88:5237-5241.
4. Burchell B (1973) Observations of uridine diphosphate glucuronyltransferase activity towards oestriol and xenobiotics in developing and cultured tissues from mouse and man. Biochem Soc Trans 1:1212-1214.
5. Cartwright RA, Glashmam RW, Rogers HJ, Ahmet RA, Barham-Hall D, Higgins E and Kahn MA (1982) Role of N-acetyltransferase phenotypes in bladder carcinogenesis: A pharmacogenetic epidemiological approach to bladder cancer. Lancet 2:842-846.
6. Cohen SN, Baumggartner R, Steinberg MS and Weber W (1973) Changes in the physiochemical characteristics of rabbit liver N-acetyltransferase during post-natal development. Biochim Biophys Acta 304:472-481.
7. Deguchi T, Mashimo M and Suzuki T (1990) Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver. J Biol Chem 265: 12757-12760.
8. Dutton GJ (1971) Glucuronide-forming enzymes, in Handbook of Experimental Pharmacology, pp 378-400. Springer-Verlag, Berlin.
9. Estrada-Rogers L, Levy GN and Weber WW (1997) Expression of arylamine N-acetyltransferase, NAT2, during development of CD1 mice. Pharmacologist 39:22.
10. Estrada-Rogers L, Levy GN and Weber WW (1998) Substrate selectivity of mouse N-acetyltransferases 1, 2 and 3 expressed in COS-1 cells. Drug Metab Dispos 24:502-505.
11. Filler R and Lew KJ (1981) Developmental onset of mixed-function oxidase activity in preimplantation mouse embryos. Proc Natl Acad Sci USA 78:6991-6995.
12. Futscher BW, Blake LL, Gerlach JH, Grogan RM and Dalton WS (1982) Quantitative polymerase chain reaction analysis of mdrl mRNA in multiple myeloma cell lines and clinical specimens. Anal Biochem 213:1-8.
13. Grant DM (1993) Molecular genetics of the N-acetyltransferases. Pharmacogenetics 3:45-50.
14. Grant DM, Blum M and Meyers UA (1992) Polymorphisms of N-acetyltransferase genes. Xenobiotica 22:1073-1081.
15. Hein D (1988) Acetylator genotype and arylamine-induced carcinogenesis. Biochim Biophys Acta 948:37-56.
16. Hickman D and Sim E (1991) N-acetyltransferase polymorphism: Comparison of phenotype and genotype in humans. Biochem Pharmacol 42:1007-1014.
17. Ilett KF, Davis BM, Detchon P, Castleden WM and Kwa R (1987) Acetylation phenotype in colorectal carcinoma. Cancer Res 47:1466-1469.
18. Lang NP, Chu DZJ, Hunter CF, Kendall DC, Flammang TJ and Kadlubar FF (1986) Role of aromatic amine acetyltransferase in human colorectal cancer. Arch Surg 121:1259-1261.
19. Martell KJ, Vatsis KP and Weber WW (1991) Molecular genetic basis of rapid and slow acetylation in mice. Mol Pharmacol 40:218-227.
20. Martell KJ, Levy GN and Weber WW (1992) Cloned mouse N-acetyltransferases: Enzymatic properties of expressed NAT1 and NAT2 gene products. Mol Pharmacol 42:265-272.
21. Minchin RF, Kadlubar FF and Ilett KF (1993) Role of acetylation in colorectal cancer. Mutat Res 290:35-42.
22. Minchin RF (1995) Acetylation of p-aminobenzoyl-glutamate, a folic acid catabolite by recombinant human arylamine N-acetyltransferase and U937 cells. Biochem J 307:1-3.
23. Ohsako S and Deguchi T (1990) Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liver. J Biol Chem 265:4630-4634.
24. Pacifici GM, Bencini C and Rane A (1986) Acetyltransferase in humans: Development and tissue distribution. Pharmacology 32:283-291.
25. Pariente-Khayat A. Pons G, Rev E, Richard M, D'Athis P, Moran C, Badoval J and Olive G (1991) Caffeine acetylator phenotyping during maturation in infants. Pediatr Res 29:492-495.
26. Perucca E (1987) Drug metabolism in pregnancy, infancy and childhood. Pharmacol Ther 34:129-143.
27. Risch A, Wallace DMA. Bathers S and Sim E (1995) Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum Mol Genet 4:231-236.
28. Smelt V, Mardon HJ and Sim E (1998) Placental expression of arylamine N-acetyltransferases: Evidence for linkage disequilibrium between NAT1*10 and NAT2*4 alleles of the two human arylamine N-acetyltransferase loci NAT1 and NAT2. Pharmacol Toxicol 83:149-157.
29. Sonawane BR (1982) Perinatal development of N-acetyltransferase in hepatic and extrahepatic tissues of guinea pigs. Pediatr Pharmacol 2:223-229.
30. Vatsis KP, Martell KJ and Weber WW (1991) Diverse point mutations in the human gene for polymorphic N-acetyltransferase. Proc Natl Acad Sci USA 88:6333-6337.
31. Vatsis K and Weber W (1997) N-acetyltransferases, in Comprehensive Toxicology. (Sipes IG, Gandolfi AJ, and McQueen CA eds) pp 385-400, Elsevier Science Inc., New York.
32. Vest MF and Salzberg R (1965) Conjugation reactions in the newborn infant: The metabolism of p-aminobenzoic acid. Arch Dis Child 40:97-105.
33. Ward A, Summers MJ and Sim E (1995) Purification of recombinant human N-acetyltransferase type I (NAT1) expressed in E, coli and characterization of its potential role in folate metabolism. Biochem Pharmacol 49:1759-1767.
34. Weber W (1987) The Acetylator Gene and Drug Response, pp 1-248, Oxford Press, New York.
35. Wells D and Kedes L (1985) Structure of a human histone cDNA: Evidence that basally expressed histone genes have intervening sequences and encode polyadenylated mRNAs. Proc Natl Acad Sci USA 82:2834-2838.
36. Wells PG and Winn LM (1996) Biochemical toxicology of chemical teratogenesis. Crit Rev Biochem Mol Biol 31:1-40.